Helenalin/NN
,/,
an/DT
anti-inflammatory/JJ
sesquiterpene/NN
lactone/NN
from/IN
Arnica/FW
,/,
selectively/RB
inhibits/VBZ
transcription/NN
factor/NN
NF-kappaB/NN
[/(
see/VB
comments/NNS
]/)

Alcoholic/JJ
extracts/NNS
prepared/VBN
form/IN
Arnicae/FW
flos/FW
,/,
the/DT
collective/JJ
name/NN
for/IN
flowerheads/NNS
from/IN
Arnica/FW
montana/FW
and/CC
A./FW
chamissonis/FW
ssp./FW
foliosa/FW
,/,
are/VBP
used/VBN
therapeutically/RB
as/IN
anti-inflammatory/JJ
remedies/NNS
./.
=====
The/DT
active/JJ
ingredients/NNS
mediating/VBG
the/DT
pharmacological/JJ
effect/NN
are/VBP
mainly/RB
sesquiterpene/NN
lactones/NNS
,/,
such/JJ
as/IN
helenalin/NN
,/,
11alpha,13-dihydrohelenalin/NN
,/,
chamissonolid/NN
and/CC
their/PRP$
ester/NN
derivatives/NNS
./.
=====
While/IN
these/DT
compounds/NNS
affect/VBP
various/JJ
cellular/JJ
processes/NNS
,/,
current/JJ
data/NNS
do/VBP
not/RB
fully/RB
explain/VB
how/WRB
sesquiterpene/NN
lactones/NNS
exert/VBP
their/PRP$
anti-inflammatory/JJ
effect/NN
./.
=====
We/PRP
show/VBP
here/RB
that/IN
helenalin/NN
,/,
and/CC
,/,
to/TO
a/DT
much/RB
lesser/JJR
degree/NN
,/,
11alpha,13-dihydrohelenalin/NN
and/CC
chamissonolid/NN
,/,
inhibit/VBP
activation/NN
of/IN
transcription/NN
factor/NN
NF-kappaB/NN
./.
=====
This/DT
difference/NN
in/IN
efficacy/NN
,/,
which/WDT
correlates/VBZ
with/IN
the/DT
compounds/NNS
'/POS
anti-inflammatory/JJ
potency/NN
in/FW
vivo/FW
,/,
may/MD
be/VB
explained/VBN
by/IN
differences/NNS
in/IN
structure/NN
and/CC
conformation/NN
./.
=====
NF-kappaB/NN
,/,
which/WDT
resides/VBZ
in/IN
an/DT
inactive/JJ
,/,
cytoplasmic/JJ
complex/NN
in/IN
unstimulated/JJ
cells/NNS
,/,
is/VBZ
activated/VBN
by/IN
phosphorylation/NN
and/CC
degradation/NN
of/IN
its/PRP$
inhibitory/JJ
subunit/NN
,/,
IkappaB/NN
./.
=====
Helenalin/NN
inhibits/VBZ
NF-kappaB/NN
activation/NN
in/IN
response/NN
to/TO
four/CD
different/JJ
stimuli/NNS
in/IN
T-cells/NNS
,/,
B-cells/NNS
and/CC
epithelial/JJ
cells/NNS
and/CC
abrogates/VBZ
kappaB-driven/JJ
gene/NN
expression/NN
./.
=====
This/DT
inhibition/NN
is/VBZ
selective/JJ
,/,
as/IN
the/DT
activity/NN
of/IN
four/CD
other/JJ
transcription/NN
factors/NNS
,/,
Oct-1/NN
,/,
TBP/NN
,/,
Sp1/NN
and/CC
STAT/NN
5/CD
was/VBD
not/RB
affected/VBN
./.
=====
We/PRP
show/VBP
that/IN
inhibition/NN
is/VBZ
not/RB
due/JJ
to/TO
a/DT
direct/JJ
modification/NN
of/IN
the/DT
active/JJ
NF-kappaB/NN
heterodimer/NN
./.
=====
Rather/RB
,/,
helenalin/NN
modifies/VBZ
the/DT
NF-kappaB/IkappaB/NN
complex/NN
,/,
preventing/VBG
the/DT
release/NN
of/IN
IkappaB/NN
./.
=====
These/DT
data/NNS
suggest/VBP
a/DT
molecular/JJ
mechanism/NN
for/IN
the/DT
anti-inflammatory/JJ
effect/NN
of/IN
sesquiterpene/NN
lactones/NNS
,/,
which/WDT
differs/VBZ
from/IN
that/DT
of/IN
other/JJ
nonsteroidal/JJ
anti-inflammatory/JJ
drugs/NNS
(/(
NSAIDs/NNS
)/)
,/,
indomethacin/NN
and/CC
acetyl/NN
salicylic/JJ
acid/NN
./.